ES2132147T3 - Triazolopiridazinas como antiasmaticos. - Google Patents

Triazolopiridazinas como antiasmaticos.

Info

Publication number
ES2132147T3
ES2132147T3 ES93104367T ES93104367T ES2132147T3 ES 2132147 T3 ES2132147 T3 ES 2132147T3 ES 93104367 T ES93104367 T ES 93104367T ES 93104367 T ES93104367 T ES 93104367T ES 2132147 T3 ES2132147 T3 ES 2132147T3
Authority
ES
Spain
Prior art keywords
optionally substituted
stands
group
lower alkyl
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93104367T
Other languages
English (en)
Inventor
Akio Miyake
Yasuhiko Kawano
Asuko Ashida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2132147T3 publication Critical patent/ES2132147T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

NUEVOS COMPUESTOS REPRESENTADOS MEDIANTE LA FORMULA: DONDE R1 ES H, UN GRUPO ALQUIL INFERIOR OPCIONALMENTE SUSTITUIDO O UN HALOGENO; R2 Y R3 DE FORMA RESPECTIVA SON UN HIDROGENO O UN GRUPO ALQUIL INFERIOR OPCIONALMENTE SUSTITUIDO, O R2 Y R3, TOMADOS CONJUNTAMENTE CON EL GRUPO -C = C NILLO DE 5DE LA FORMULA: (R4 Y R5 RESPECTIVAMENTE SON H O UN GRUPO ALQUIL INFERIOR OPCIONALMENTE SUSTITUIDO) O UN GRUPO DIVALENTE DERIVADO A PARTIR DE UN ANILLO HETEROCICLICO U HOMOCICLICO OPCIONALMENTE SUSTITUIDO DE 3 ES H, O UN GRUPO ALQUIL INFERIOR OPCIONALMENTE SUSTITUIDO, UN GRUPO CICLOALQUIL OPCIONALMENTE SUSTITUIDO O UN GRUPO ARIL OPCIONALMENTE SUSTITUIDO, O R6 Y R7 PUEDEN, TOMADOS CONJUNTAMENTE CON EL N ADYACENTE, FORMAR UN GRUPO HETEROCICLICO OPCIONALMENTE SUSTITUIDO CONTENIENDO N; M ES 0 HASTA 4; N ES 0 HASTA 4, O UNA SAL DE ELLOS, QUE TIENE ACTIVIDADES EXCELENTES ANTI PAF, ACTIVIDADES ANTI LTC4 Y ACTIVIDADES ANTI ET-1, Y ES DE GRAN VALOR COMO AGENTE ANTIASMATICO, Y SU PRODUCCION, INCLUYENDO LAS COMPOSICIONES INTERMEDIAS Y FARMACEUTICAS.
ES93104367T 1992-03-18 1993-03-17 Triazolopiridazinas como antiasmaticos. Expired - Lifetime ES2132147T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6178092 1992-03-18
JP21890492 1992-08-18
JP1456093 1993-02-01

Publications (1)

Publication Number Publication Date
ES2132147T3 true ES2132147T3 (es) 1999-08-16

Family

ID=27280691

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93104367T Expired - Lifetime ES2132147T3 (es) 1992-03-18 1993-03-17 Triazolopiridazinas como antiasmaticos.

Country Status (22)

Country Link
US (1) US5389633A (es)
EP (1) EP0562439B1 (es)
CN (1) CN1040874C (es)
AT (1) ATE181075T1 (es)
AU (1) AU654430B2 (es)
CA (1) CA2091874A1 (es)
DE (1) DE69325199T2 (es)
DK (1) DK0562439T3 (es)
EE (1) EE9400357A (es)
ES (1) ES2132147T3 (es)
FI (1) FI104076B1 (es)
GR (1) GR3030817T3 (es)
HK (1) HK1009700A1 (es)
HU (2) HU218791B (es)
LT (1) LT3200B (es)
LV (1) LV10456B (es)
MY (1) MY108967A (es)
NO (1) NO300774B1 (es)
NZ (1) NZ247171A (es)
PH (1) PH29998A (es)
RU (1) RU2130458C1 (es)
TW (1) TW255891B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) * 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) * 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US5464853A (en) * 1993-05-20 1995-11-07 Immunopharmaceutics, Inc. N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en) * 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en) * 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5736509A (en) * 1990-12-14 1998-04-07 Texas Biotechnology Corporation Cyclic peptide surface feature mimics of endothelin
US5482939A (en) * 1992-03-18 1996-01-09 Takeda Chemical Industries, Ltd. Triazolopyridazine compounds, their production and use
ATE168376T1 (de) * 1993-04-12 1998-08-15 Takeda Chemical Industries Ltd Triazolopyridazin-derivate, ihre herstellung und verwendung
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
TW304878B (es) * 1993-09-21 1997-05-11 Takeda Pharm Industry Co Ltd
DE69521209T2 (de) * 1994-09-16 2002-03-07 Takeda Chemical Industries Ltd Triazolopyridazine, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel
US5977117A (en) 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5804585A (en) * 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
CA2285264A1 (en) * 1997-04-25 1998-11-05 Michiyo Gyoten Condensed pyridazine derivatives, their production and use
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
HU227183B1 (en) 1997-04-28 2010-09-28 Encysive Pharmaceuticals Inc Sulfonamide derivatives and pharmaceutical compositions containing them for the treatment of endothelin-mediated disorders
WO1999044611A1 (en) * 1998-03-04 1999-09-10 Takeda Chemical Industries, Ltd. Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases
CA2346659A1 (en) 1998-10-06 2000-04-13 Michiyo Gyoten Condensed pyridazine compounds, their production and use
CA2348022A1 (en) 1998-10-21 2000-04-27 Takeda Chemical Industries, Ltd. Condensed pyridazine derivatives, their production and use
KR20100120139A (ko) * 2008-02-05 2010-11-12 사노피-아벤티스 Ｐａｒ１ 억제제로서의 트리아졸륨 염, 이들의 제조방법, 및 약제로서의 용도
SG182297A1 (en) 2009-12-31 2012-08-30 Ct Nac Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
WO2012098387A1 (en) 2011-01-18 2012-07-26 Centro Nacional De Investigaciones Oncológicas (Cnio) 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
WO2013005057A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncológicas (Cnio) New compounds
WO2013005041A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncológicas (Cnio) Tricyclic heterocyclic compounds as kinase inhibitors
WO2013004984A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncologicas (Cnio) Tricyclic compounds for use as kinase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915968A (en) 1973-09-21 1975-10-28 Lepetit Spa Triazolopyridazines
US4136182A (en) 1976-05-26 1979-01-23 The Dow Chemical Company Triazolopyridazines used to alleviate bronchial spasms
PH27291A (en) * 1989-01-31 1993-05-04 Takeda Chemical Industries Ltd Imidazolpyrimidazines their production and use
EP0440119A1 (en) * 1990-01-31 1991-08-07 Takeda Chemical Industries, Ltd. Imidazopyridazine compounds, their production and use
DE69106902T2 (de) * 1990-03-01 1995-07-06 Takeda Chemical Industries Ltd Imidazopyridazine, ihre Herstellung und Verwendung.

Also Published As

Publication number Publication date
AU3526993A (en) 1993-09-23
NO300774B1 (no) 1997-07-21
NO930974L (no) 1993-09-20
MY108967A (en) 1996-11-30
RU2130458C1 (ru) 1999-05-20
FI931190A0 (fi) 1993-03-17
TW255891B (es) 1995-09-01
ATE181075T1 (de) 1999-06-15
DK0562439T3 (da) 1999-11-15
DE69325199D1 (de) 1999-07-15
EP0562439A1 (en) 1993-09-29
GR3030817T3 (en) 1999-11-30
NZ247171A (en) 1994-09-27
CA2091874A1 (en) 1993-09-19
CN1040874C (zh) 1998-11-25
DE69325199T2 (de) 1999-12-16
FI931190A (fi) 1993-09-19
LV10456A (lv) 1995-02-20
HU218791B (hu) 2000-12-28
PH29998A (en) 1996-10-29
HU9300759D0 (en) 1993-06-28
LT3200B (en) 1995-03-27
LV10456B (en) 1995-10-20
HU211326A9 (en) 1995-11-28
HK1009700A1 (en) 1999-06-04
CN1077958A (zh) 1993-11-03
LTIP390A (lt) 1994-08-25
FI104076B (fi) 1999-11-15
AU654430B2 (en) 1994-11-03
US5389633A (en) 1995-02-14
NO930974D0 (no) 1993-03-17
EE9400357A (et) 1996-04-15
EP0562439B1 (en) 1999-06-09
FI104076B1 (fi) 1999-11-15
HUT65935A (en) 1994-08-29

Similar Documents

Publication Publication Date Title
ES2132147T3 (es) Triazolopiridazinas como antiasmaticos.
ATE124695T1 (de) Kondensierte heterocyclische verbindungen, ihre herstellung und verwendung.
ATE338754T1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung
DE69431576T2 (de) Isoxazole Derivate und ihre Verwendung als Herbizide
DE68920796T2 (de) Chinolinderivate, ihre Herstellung und Verwendung.
AU652981B2 (en) Condensed benzoxa ring compound, production thereof, and pharmaceutical composition containing the same
ATE205199T1 (de) Quinolin- oder quinazolinderivate, deren herstellung und verwendung
ATE238298T1 (de) Tetraderivate, ihre herstellung und verwendung
ATE97410T1 (de) 6-amino-6-desoxyfumagillole, ihre herstellung und ihre verwendung.
DE69322673D1 (de) Imidazopyridazine als Antiasthmatika
GR77088B (es)
ATE61362T1 (de) Ein thiophenderivat und verfahren zu dessen herstellung.
GB1480593A (en) Xanthene and thioxanthene derivatives having pharmaceutical activity
SE7905051L (sv) Nya sulfonamider
DE69022660T2 (de) Verfahren zur Herstellung von Carbamatderivaten des Lankacidines.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 562439

Country of ref document: ES